Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128
Sort by:

North America Compression Stockings Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... North America Compression Stockings market. Chapter 1, to describe Compression Stockings Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Compression Stockings ...

February 2017 116 pages

Global Chondroitin Sulfate Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 3,480.00

... Grade Market Segment by Applications, can be divided into Pharmaceutical Dietary Supplements Cosmetics Veterinary Use There are 15 Chapters to deeply display the global Chondroitin Sulfate market. Chapter 1, to describe Chondroitin Sulfate Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Chondroitin Sulfate, with ...

February 2017 117 pages

Global Compression Stockings Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 3,480.00

... Market Segment by Applications, can be divided into Ambulatory Patients Post-operative Patients Pregnant Women There are 15 Chapters to deeply display the global Compression Stockings market. Chapter 1, to describe Compression Stockings Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Compression Stockings, with ...

February 2017 115 pages

Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro-Kinetic Agents), By Region, And Segment Forecasts, 2014 - 2025

US$ 5,950.00

... Gastroesophageal Reflux Disease (GERD) therapeutics market is expected to reach USD 4.34 billion by 2025, according to a new study by Grand View Research, Inc. The incidence of acid reflux ... subset hence forms a prominent target population for GERD therapeutics. Further key findings from the study suggest: ...

February 2017 80 pages

Global Hepatitis Drugs Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023

US$ 2,500.00

... hepatitis drugs market in the future. Market Analysis: The “Global Hepatitis Drugs Market” is estimated to witness a CAGR of 15.0% during the forecast period 2017–2023. The Hepatitis Drugs market ... Analysis: At present, the HCV drugs are dominating the Global Hepatitis Drugs market – but, a lot of new ...

February 2017 87 pages

Global Small Cell Market Analysis & Forecast Report 2017-2022

US$ 2,600.00

The Global Small Cell Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of the Small Cell Market. The report analysis the global market of Small Cell by main manufactures and geographic regions. The report includes Small Cell definitions, classifications, applications and ...

February 2017 105 pages

Women’s Health Rehabilitation Products Market Analysis By Product (Orthopedic Care, Urinary Incontinence, Breast Cancer Care, Pregnancy & Postpartum Care), By Therapy (Physical Therapy, Occupational Therapy), And Segment Forecasts, 2014 - 2025

US$ 5,950.00

The global women’s health rehabilitation products market is expected to reach USD 4.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth ...

February 2017 100 pages

Indian Anti-Aging Market Outlook 2022

US$ 800.00

... market’s growth. The latest research by RNCOS titled, “Indian Anti-Aging Market Outlook 2022”, illustrates the current and future scenario of Indian Anti-Aging market. In the report, the Indian Anti-Aging market ...

February 2017 30 pages

Indian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020

US$ 1,500.00

... market’s growth. Owing to such factors, the Indian influenza market is anticipated to grow at a healthy CAGR during the forecast period (2015-2020). In the report “IIndian Influenza Market By Product ... the market share of key players, such as Cipla Ltd., Bharat Biotech, Serum Institute of India, Abbott, Lupin ...

February 2017 90 pages

Global Hip Orthosis Market Analysis & Forecast Report 2016-2021

US$ 2,600.00

The Global Hip Orthosis Market Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the Hip Orthosis Market. The report analysis the global market of Hip Orthosis by main manufactures and geographic regions. The report includes Hip Orthosis definitions, classifications, applications and ...

February 2017 103 pages

Global Telemedicine Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2021

US$ 1,500.00

... (2009 - 2021) 6. Telemedicine Market and Forecast - by Region (2009 - 2021) 7. Global Telemedicine Market - Mergers and Acquisitions (2013 - 2016) 8. Global Telemedicine Market - Driving Factors and Challenges 9. Global Telemedicine Market - Company Profiles, Revenue and Recent Developments Global Telemedicine Market and Forecast ...

February 2017 142 pages

Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers

US$ 1,150.00

Germany Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers is a market research report published by Renub Research. According to this report Germany Proton Therapy Industry has a market potential of US$ 2 Billion by 2021. Currently Germany has ...

February 2017 51 pages

France Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers

US$ 1,150.00

France Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers is a report published by Renub Research. France Proton Therapy Market is expected to be more than USD 1.5 Billion by the year 2021. France Proton Therapy actual market is expected to almost double in future ...

February 2017 51 pages

Healthcare Claims Management Solutions Market by Type (Software, Hardware, and Services], and Deployment mode (Web-based, Cloud-based, and On-premise) - Global Opportunity Analysis and Industry Forecast, 2014-2022

US$ 5,370.00

... Issues Hamper The Growth Of The Market. The Global Healthcare Claims Management Solutions Market Is Segmented Based On Type, Deployment ... Determine The Competitive Outlook Of The Global Healthcare Claims Management Market. Healthcare Claims Management Solutions Market Key Segments By Type Software Hardware ...

February 2017 140 pages

Nuclear Medicine Equipment Market by Product Type (SPECT and PET), Application (Neurology, Oncology, Cardiology, and Others), and End User (Hospitals, Imaging Centers, and Academic & Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022

US$ 5,540.00

... , which is expected to positively impact the market growth. The nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in adoption of nuclear medicine equipment, and emergence of innovative & advanced ...

February 2017 170 pages

Radiology Information System Market by Type (Integrated Radiology Information Systems, and Standalone Radiology Information Systems), by Component (Services, Software, and Hardware), by Deployment Mode (Web-Based, On-Premise, and Cloud-Based), and by End User (Hospitals, Office-Based Physicians, Emergency Healthcare Service Providers, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

US$ 5,540.00

... Of Global Radiology Information System Market Radiology Information System Market Key Segment The Radiology Information Systems Market Is Segmented Into Type, Component, Deployment Mode, End User, And Geography. By Type Integrated Radiology Information Systems Standalone Radiology Information Systems Market ...

February 2017 160 pages

Epiomic Epidemiology Series: Bell's Palsy Forecast in 15 Major Markets 2017-2027

US$ 6,150.00

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources used ... co-morbid conditions on Bell’s palsy incident population. Identify sub-populations within Bell’s palsy which require treatment. ...

February 2017 62 pages

Epiomic Epidemiology Series: Mucopolysaccharidosis-II (MPS-II) Hunter Syndrome Forecast in 26 Major Markets 2017-2027

US$ 6,150.00

Mucopolysaccharidosis-II, also known as MPS-II or Hunter syndrome, is part of the Mucopolysaccharidoses (MPS) disorders - a group of rare genetic disorders caused by deficiencies of lysosomal enzymes. MPS ... the proprietary Epiomic patient segmentation database. ... , clinical trials and epidemiology studies. All of ...

February 2017 102 pages

Epiomic Epidemiology Series: Mucopolysaccharidosis-III (MPS-III) Sanfilippo Syndrome Forecast in 23 Major Markets 2017-2027

US$ 6,150.00

Mucopolysaccharidosis-III, also known as MPS-III or Sanfilippo syndrome, is part of the Mucopolysaccharidoses (MPS) disorders - a group ... sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ...

February 2017 74 pages

Epiomic Epidemiology Series: Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027

US$ 6,150.00

... sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Non-Hodgkin Lymphoma incident population. Identify sub-populations within Non-Hodgkin Lymphoma which require treatment ...

February 2017 92 pages

Alzheimer's Disease Forecast in 12 Major Markets 2017-2027

US$ 6,150.00

... the main disease are also included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Alzheimer’s disease include: Other ... on the impact from specific co-morbid conditions on Alzheimer’s disease’s prevalent population. Identify sub-populations within Alzheimer’s disease which require treatment. Gain an understanding of the ...

February 2017 56 pages

Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027

US$ 6,150.00

... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Irritable Bowel Syndrome include: Abdominal pain Abdominal cramping Bloated ... on the impact from specific co-morbid conditions on Irritable Bowel Syndrome prevalent population. Identify sub-populations within Irritable Bowel Syndrome which require treatment. Gain an understanding of the ...

February 2017 48 pages

Lewy Body Dementia Forecast in 12 Major Markets 2017-2027

US$ 6,150.00

... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Lewy Body Dementia disease include: Problems with alertness and ... on the impact from specific co-morbid conditions on Lewy Body Dementia prevalent population. Identify sub-populations within Lewy Body Dementia which require treatment. Gain an understanding of the ...

February 2017 48 pages

Liver Cancer Forecast in 18 Major Markets 2017-2027

US$ 6,150.00

Liver Cancer, also known as hepatic cancer or primary liver cancer, is a cancer which starts in the cells of the liver. The most common form is hepatocellular carcinoma (HCC) which originates ... level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Liver Cancer include: Type 2 Diabetes Mellitus Liver Cirrhosis Hepatitis C Hepatitis B This ...

February 2017 64 pages

Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027

US$ 6,150.00

... are also included at a country level across the 10-year forecast snapshot. The following conditions and comorbidities are ... from specific co-morbid conditions on Osteopenia and Osteoporosis prevalent population. Identify sub-populations within Osteopenia and Osteoporosis which require treatment. Gain an ...

February 2017 84 pages

Hearing Loss Forecast in 12 Major Markets 2017-2027

US$ 6,150.00

... to the brain (neural loss). It should be noted that hearing loss can be temporary in some instances, such as conductive hearing loss due to infection. Hearing loss can occur in one (bilateral ... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Hearing Loss include: Vertigo Tinnitus Hyperacusis Depression This ...

February 2017 48 pages

AML: KOL Insight [2017]

US$ 8,145.00

... how KOLs see the market evolving, and how they expect developers to differentiate their pipeline therapies in KOL Insight: Acute Myeloid Leukaemia (AML). Twelve US and European KOLs give their insight on two off-label marketed products and 16 pipeline programmes. KOLs also ...

February 2017 -

Cystic Fibrosis: KOL Insight [2017]

US$ 8,145.00

... life expectancy of ~40 years? Learn how KOLs see the CF market evolving in KOL Insight: Cystic Fibrosis (CF). 12 US and European KOLs provide candid insights on 4 marketed and 12 emerging therapies targeting ... full list now Sample of KOLs interviewed KOLs from North America Dr Patrick Flume, MD, Powers-Huggins Endowed Chair for Cystic Fibrosis, Professor of Medicine and ...

February 2017 -

Market Access Impact (EU5) [Melanoma]

US$ 5,145.00

... up the top and middle of the market, and help the last place brand double its share in Market Access Impact: Melanoma (US). Based on a survey of 150 oncologists ... ; Roche) Exploring Important Market Access Issues Market Access Impact: Melanoma (EU5) explores key issues affecting Melanoma drug manufacturers. You’ll learn: How barriers affect market access What brands do doctors ...

February 2017 -

Market Access Impact (US) [Melanoma]

US$ 5,145.00

... , and what your brand can do to level the playing field in Market Access Impact: Melanoma (US). Based on a survey of 100 oncologists and dermato-oncologists, the report ... (vemurafenib; Roche) Exploring Market Access Barriers Market Access Impact: Melanoma (US) explores key issues affecting melanoma drug manufacturers. You’ll learn: How barriers affect market access What brands do doctors ...

February 2017 -

Medical Affairs Reputations (EU5) [PsO]

US$ 6,175.00

Compare 10 psoriasis medical affairs teams. See how your team stacks up to the market leader In the EU5, several of the psoriasis medical affairs teams we surveyed are ... ?” Discover all the ways you can improve your medical affair services in Medical Affairs Reputations: Psoriasis (EU5). Purchase your copy now Comparing 10 major Psoriasis treatments ...

February 2017 -

Medical Affairs Reputations (US) [PsO]

US$ 6,175.00

... improve your medical affair services in Medical Affairs Reputations: Psoriasis (US). Purchase your copy now Discover all the ways you can improve your medical affair services in Medical Affairs Reputations: Psoriasis ... Competitive View of Your Medical Affairs Team Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 8 medical affairs teams—answering important ...

February 2017 -

NPS+ (EU5) [Cancer Pain]

US$ 2,575.00

... leaders in FirstView’s NPS+ Cancer Pain 2017 (EU5). Based on a survey of 150 EU5-based medical oncologists, the report builds on the respected net promoter score (NPS) to compare ... NPS+ Cancer Pain Management 2017 (EU5) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn How satisfied doctors are with cancer pain ...

February 2017 -

NPS+ (EU5) [Parkinson's Disease]

US$ 2,575.00

... widespread dissatisfaction among doctors Neurologists in the EU5 countries are not happy with available Parkinson’s disease treatments, and it shows. According to our survey ... Issues NPS+ Parkinson’s Disease 2017 (EU5) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn: How satisfied doctors are with Parkinson’s disease ...

February 2017 -

NPS+ (EU5) [RCC]

US$ 2,575.00

... marketers and market access specialists, NPS+ Renal Cell Carcinoma brings focus and clarity for 8 leading RCC treatments. See not only ... and your competitors’ offerings. Get Answers to Key Questions About RCC Treatments Afinitor (everolimus): Which three key messages have made ... Important Brand Loyalty Issues NPS+ Renal Cell Carcinoma (EU5) looks into the perceptions and views impacting RCC brand loyalty from the ...

February 2017 -

NPS+ (US) [Cancer Pain]

US$ 2,575.00

... leader in FirstView’s NPS+ Cancer Pain 2017 (US). Based on a survey of 100 US-based medical oncologists, the report builds on the respected net promoter score (NPS) to compare ... 11th and 16th, 2017. Explore Important Brand Loyalty Issues NPS+ Cancer Pain Management 2017 (EU5) explores key issues affecting brand loyalty ...

February 2017 -

NPS+ (US) [Parkinson's Disease]

US$ 2,575.00

... ’s NPS+ Parkinson’s Disease 2017 (US). Based on a survey of 100 US-based neurologists, the report builds on the respected net promoter score (NPS) to compare loyalty for 11 major Parkinson ... Issues NPS+ Parkinson’s Disease 2017 (US) explores key issues affecting brand loyalty for drug manufacturers. You’ll learn How satisfied doctors are with Parkinson’s disease ...

February 2017 -

NPS+ (US) [RCC]

US$ 2,575.00

... marketers and market access specialists, NPS+ Renal Cell Carcinoma brings focus and clarity for 9 leading US RCC treatments. See not only ... and your competitors’ offerings. Get Answers to Key Questions About RCC Treatments Afinitor (everolimus): Which two key messages are getting ... Important Brand Loyalty Issues NPS+ Renal Cell Carcinoma (US) looks into the perceptions and views impacting RCC brand loyalty from the ...

February 2017 -

Overcoming Market Access Barriers to High Value Drugs

US$ 2,245.00

... of market access barriers on prescriptions for Psoriasis, HIV, Multiple Sclerosis, and Rheumatoid Arthritis The challenges for overcoming market access barriers in oncology and immunology Recommendations for overcoming market access barriers Key Benefits Understand how the biosimilar market has grown in 2016 ...

February 2017 -

Targeted Therapies in Asthma [2017]

US$ 8,145.00

... new targeted asthma therapies emerge, is time running out for Xolair? Xolair’s unique position in the targeted asthma treatment market is under threat. Teva’s Cinqair and ... , and how they expect developers to differentiate their pipeline asthma antibodies in KOL Insight: Targeted Therapies in Asthma. Twelve US and European KOLs give their insight ...

February 2017 -

Feasibility Report of Hospital in Kuwait

US$ 42.00

In this project first of all the idea of hospital was developed. The main aim of this project was to develop State of Art hospital in Kuwait that has latest medical facilities. Cont... (2000 words of this report)

January 2017 11 pages

Code of Ethics of Nutritions in Kuwait

US$ 30.00

... code of ethics in all fields, particularly in the field of dietetics and nutrition. In general by ethics it is meant acceptable values in particular society. All professions have certain ethics and ... and nutrition. Kuwait is an Islamic nation and all the national codes of ethics don’t apply as it is, so there is a need that it should have its own code of ethics in accordance ...

January 2017 3 pages

Plastic Surgeries in Kuwait, Research Essay

US$ 35.00

... curses associated with the plastic surgery, influence of the plastic surgery on the Kuwaiti society and as how the celebrities with the plastic surgery impacted the people ... the general people of the Kuwait so that to judge their opinion regarding the three major aspects of the plastic surgery selected by us. Sample of 150 people ...

January 2017 12 pages

Global Healthcare Exoskeletons Market 2016-2023: Structure Analysis, Trend Outlook and Business Strategy

US$ 2,516.00

... forecast years. Global Healthcare Exoskeletons Market 2016-2023: Structure Analysis, Trend Outlook and Business Strategy is based on a comprehensive research of the healthcare exoskeletons market by analyzing the entire global market and all ...

January 2017 141 pages

Global Nanomedicine Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023

US$ 2,500.00

... also pass multiple clinical studies. The major drivers of the nanomedicine market include its application in various therapeutic areas, ... segment is expected to drive the growth of the nanomedicine market in the future. Market Analysis: The “Global Nanomedicine Market” is estimated to witness a CAGR of 17.1% ...

January 2017 93 pages

Global Tretinoin Market by Manufacturers, Regions, Type and Application, Forecast to 2022

US$ 3,480.00

... 0.1% Tretinoin 0.02% Tretinoin 0.025% Tretinoin 0.05% Tretinoin Market Segment by Applications, can be divided into Skin Use Leukemia There are 13 Chapters to deeply display the global Tretinoin market. Chapter 1, to describe Tretinoin Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Tretinoin, with sales ...

January 2017 117 pages

Global Healthcare Information Systems Market Research and Analysis, 2015-2022

US$ 3,495.00

... Systems Market by Delivery Mode On-Premises Cloud-based Web-based Healthcare Information Systems Market by Application Hospital Information Systems Laboratory Information Systems Pharmacy Information Systems OMR report covers: Comprehensive research methodology of global healthcare information systems market ...

January 2017 -

Healthcare Cybersecurity Market - Forecasts from 2017 to 2022

US$ 3,600.00

Healthcare cybersecurity is a thriving market for players in the industry are increasingly going digital with ... the healthcare cyber security market. In 2022, the market for Global Healthcare Cyber Security is projected to witness compound annual growth rate of 12.73% over the forecast period ...

January 2017 81 pages

Global Nicotine Gum Consumption Market by Manufacturers, Regions, Type and Application, Forecast to 2021

US$ 3,480.00

... display the global Nicotine Gum Consumption market. Chapter 1, to describe Nicotine Gum Consumption Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Nicotine Gum Consumption, with ...

January 2017 122 pages

Structural Biology & Molecular Modeling Techniques Market Analysis By Tools (SaaS & Standalone Modeling, Homology Modeling, Threading, Molecular Dynamics, Ab Initio, Visualization & Analysis, Databases), By Application, And Segment Forecasts, 2014 - 2025

US$ 5,950.00

... activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This ... agents In 2015, North America dominated the global structural biology & molecular modeling techniques market owing to the presence of a wide ...

January 2017 95 pages

Filters

Search

Categories

1,254
193
212
1,214
34
241
217
160
142
64,306
1,332
1,265
2,373
185

Publishers

649
541
179
32
1
1,509
34
239
366
389
103
148
348
3
202
3
6
1,623
487
80
123
208
112
31
1,049
383
23
40
68
513
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,530
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
385
8
3
18
58
913
6
89
12
24
15
1,286
229
128
386
3
74
10
119
227
46
474
26
133
4

Regions

201
97
86
75
74
50
48
42
41
40
36
36
35
31
30
29
28
27
27
26
24
24
18
17
17
17
17
16
16
15
13
12
12
11
10
9
8
8
8
7
7
6
6
6
6
5
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
798
552
2
2
2
118
198
104
61
38
709
75
136
531
215
1,137
66,824

Price

—

Date

—

Pages

—

Offers

1
280
1
1